Health Trials

Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

ConditionsVenous Embolism of Lower Extremities (Diagnosis)Arterial Embolism and ThrombosisAcute DVT of Lower ExtremityChronic DVT of Lower ExtremityDVTDeep Vein Thrombosis LegThrombus in the Peripheral Venous VasculaturePeripheral Arterial DiseaseAcute Limb IschemiaLower Extremity Acute Limb IschemiaLE ALI
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age22+
SponsorMedtronic Endovascular

About this trial

The purpose of Case-Specific Health Care Professional (HCP) Clinical Survey of Liberant™ Thrombectomy System, also known as the Liberant Clinical Assessment, is to collect first-in-human clinical data to confirm the safety and performance of the Medtronic Liberant™ thrombectomy system when used for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems

Eligibility criteria

Qualifiers

Patient treated is age ≥ 22 years at the time of procedure

Use of Liberant in accordance with the device labeling within 72 hours of index procedure

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Liberant Thrombectomy System

Treatment groups

No treatment groups listed

Locations

2
MedStar Health003329, Washington D.C.District of Columbia, United States
Naples Comprehensive Health34108, NaplesFlorida, United States

Sponsors and collaborators

Medtronic Endovascular

Lead sponsor

Source ClinicalTrials.gov